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ABSTRACT
Objective: The objective of this study is to investigate the variations, if any, in the types of intestinal parasites in HIV-positive and HIV-negative 
individuals.
Methods: Study group 75 HIV positive cases, Control group  HIV non reactive 51, total 125 faecal sample examined For  HIV conformation  screening 
test like TRI DOT, ELISA ,  for conformation HIV by using PCR, for stool examination used by following test like microscopic examination, formal ether 
concentration technique, saline wet mount,iodine wet mount, formal ethe sedimentation , modified acid fast stain.
Results: For the purpose of statistical analysis, the enteric parasites are divided into the coccidian group (Cryptosporidium+Isospora belli) and 
conventional enteric parasites (Entamoeba histolytica, Giardia intestinalis, and Ascaris lumbricoides), and enteric parasitic infection is more common 
in HIV-positive patients with diarrhea than HIV-positive patient without diarrhea or HIV-negative individuals.
Conclusion: The study period of 1 year and 8 months revealed that it is difficult to locate/identify a HIV-positive person in a place like Kadapa on 
account of confidentiality/lack of awareness among the population. Detection of intestinal parasites is 17.3% in HIV-positive patients and 12% in 
HIV-negative individuals.
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INTRODUCTION
Since the original description of acquired immunodeficiency syndrome 
(AIDS) in 1981 by Michael Gottlieb et al. in Losangeles, USA, a wide 
variety of gastrointestinal manifestations mainly opportunistic enteric 
parasitic infestations are described in patients with HIV infection [1]. 
Diarrhea is a common clinical manifestation of these infections. 
Identification of the etiological agent of diarrhea in HIV patient is very 
important as it can help in the institution of appropriate therapy and 
reduction of morbidity and mortality [2].
It has been estimated that 30–50% of patients with AIDS in the USA 
and about 90% in Africa and Haiti suffer from chronic diarrhea [3]. 
Infection caused by different pathogens cannot be differentiated 
clinically unless specific fecal examination is carried out. The isolation 
rates of intestinal parasites in patients with AIDS and chronic diarrhea 
vary from 40% to 83%, and the parasitic agents also differ markedly 
from region to region [3]. Until AIDS epidemic, several of the presently 
recognized parasitic infections were almost unknown as the cause of 
human diseases [1].
Diarrhea is the presenting symptom of approximately a third of 
patients with HIV infection. Chronic diarrhea significantly reduces 
the quality of life in patients with HIV infection and is an independent 
predictor of mortality in AIDS. A variety of enteric pathogens have 
been isolated from AIDS patients with diarrhea, but it is not clear that 
these enteric infections are necessarily associated with the presence 
of diarrhea [4]. The diarrhea wasting syndrome in association with 
a positive HIV serology test is an AIDS-defining illness in the World 
Health Organization (WHO)’s classification [5]. Cryptosporidium 
and Isospora belli, two of the intestinal coccidian parasites known to 
be the causative agents of diarrhea in animals, have now emerged 
as one of the main causes of prolonged life-threatening diarrhea in 
immunocompromised hosts particularly so in patients with AIDS [6]. 
Intestinal microsporidiosis and cyclosporiasis have also been reported 
with increasing frequency in HIV-infected patients [7]. In HIV-infected 
patients, progressive decline in their immunological responses makes 
them extremely susceptible to a variety of common and opportunistic 
infections.
METHODS
The present study was conducted from July 2014 to December 2016 
FIMS, Kadapa.
Study group
Seventy-five HIV-reactive (positive) patients (age 15–59 years) were 
identified with the help of clinicians of RIMS and FIMS. These patients 
were being treated by the clinicians for recurring ailments. The study 
group comprised of 55 male and 20 female HIV-positive patients.
Control group
Fifty HIV non-reactive individuals (34 male and 16 female), aged 
18-60 years, admitted in RIMS and FIMS, Kadapa, for various ailments 
in surgical wards were included in the study as a control group. Stool 
samples were collected from these patients after collecting relevant 
information such as age, sex, occupation, present complaint, whether 
on antiretroviral therapy (ART), and treatment given. Both diarrheic 
and non-diarrheic stool samples were collected for parasitological 
examination.
Total number of fecal samples examined = 125.
Laboratory diagnosis of HIV infection
The HIV-positive cases included in this study were identified through 
the clinicians, who were treating them for their recurrent ailments. 
They were investigated and identified as HIV reactive by serological 
tests done elsewhere. All of the patients were reported enzyme-linked 
immunoasorbant assay (ELISA) positive (as per WHO strategy-II 1993) 
for HIV-1/HIV-2 with at least two different kits [1].
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The individuals included under the control group were screened for 
their HIV status in our laboratory by ELISA and TRIDOT [7]. Method 
during admission into surgical wards at RIMS and FIMs, during July 
2014 to December 2016.
Collection of samples
Fecal sample
From each patient, one freshly voided stool sample was collected in a clean, 
wide-mouth sterile container and examined within 2–3 h of collection.
Processing of samples
Fecal sample
Naked eye examination: Color, consistency, and presence of any 
parasitic forms in the stool were noted.
Microscopic examination
Each sample was subjected to microscopic examination for the presence 
of any protozoal cyst or trophozoites, helminthic ova or larvae, or any 
other relevant findings. Saline mount and iodine (Lugol’s) wet mount 
were prepared and examined under the microscope using 10× and 40× 
objectives and findings were noted.
Formal-ether concentration technique for parasites
Each stool sample was subjected to formal-ether concentration 
technique, and the concentrated sediment is examined by saline wet 
mount and iodine wet mount to detect the parasitic forms. Thin smear 
is prepared from the deposit, heat fixed, and stained by modified 
Ziehl–Neelsen staining technique. Procedures were according to the 
standard methods mentioned in the appendix. [Saline wet mount, 
iodine wet mount, formal ether concentration technique, and modified 
Z-N staining]. Microscopic pictures of the parasitic forms were taken on 
the spot, with the binocular microscope MOTIC B-1 series with inbuilt 
digital camera, available in the Department of Microbiology, Fathima 
Institute of Medical Sciences, Kadapa, Andhra Pradesh.
Saline wet mount
Saline wet mount is made by mixing a small quantity of feces with a 
drop of physiological saline. It is seen under low- and high-power 
microscopy. It is used to demonstrate helminthic eggs and larvae. It is 
also used to detect motile trophozoites of the intestinal protozoa [8].
Iodine wet mount
Iodine wet mount is made using a drop of iodine for preparation of wet 
mount of stool. Dobell and O’Connor’s and Lugols’ and D’Antonie’s iodine 
are different types of iodine frequently used in the iodine wet mount. 
Iodine wet mount is mainly used for protozoal cysts. Iodine stained cysts 
show pale refractile nuclei, yellowish cytoplasm, and brown glycogen 
material. The chromatoidal bodies are not clearly visible. The motility of 
trophozoites is inhibited in iodine wet mount [9,10].
Formalin ether sedimentation method for parasites [9]
The advantage of this method is that formalin fixes the eggs, larvae, and 
cysts so that they become non-infectious. The procedure consists of the 
following steps:
•	 Half	teaspoon	of	fresh	stool	is	taken	in	a	15	ml	screw-capped	test	tube.	
It is mixed with 10% formalin and is allowed to stand for 30 min.
•	 The	 fecal	 suspension	 is	 filtered	 through	 two	 layers	of	gauze	 in	a	
funnel into the centrifuge tube. Saline is added to the tube to bring 
the	fluid	level	within	several	millimeters	of	the	rim	of	the	tube.	The	
tube is centrifuged for 10 min at 500 g.
•	 The	supernatant	is	discarded.	The	sediment	is	resuspended	in	saline	
and again centrifuged for 10 min at 500 g.
•	 The	sediment	is	resuspended	in	7	ml	of	10%	formalin.	3	ml	of	ether	
or ether substitute is added to it. The tube is closed with a stopper 
and shaken vigorously for 30 s. The tube is held in such a way that the 
stopper is held away from the face. The stopper is removed carefully.
•	 The	tube	is	centrifuged	for	10	min	at	500	g.	The	tube	is	then	allowed	
to	stand	in	a	test	tube	stand.	Four	layers	are	formed.	The	first	bottom	
layer is the sediment which contains parasitic forms, second layer is 
the layer of formalin, third is the layer of fecal debris, and top is the 
layer of ether or ether substitute.
•	 The	layer	of	fecal	debris	is	removed	by	an	applicator	stick	from	the	
site of the tube, and then, all the liquid is decanted leaving behind 
a drop of formalin and the sediment. The sediment is mixed with 
formalin drop, and either a wet mount is prepared for microscopic 
examination	or	a	smear	is	made	for	modified	Z-N	staining.
Modified acid-fast stain [9,10]
The modified acid-fast stain is now increasingly being used for 
the detection and identification of Cryptosporidium, Isospora, and 
Cyclospora oocysts. Both hot and cold modified acid-fast stains have 
been used with equal sensitivity. The staining solution contains:
1. Carbol fuschin: It contains basic fuschin 4 g; phenol 8 ml; alcohol 
(95%) 20 ml; and distilled water 100 ml. The carbol fuschin solution 
is prepared by mixing basic fuschin in the alcohol. To this mixture, 
water is added slowly while shaking. 8 ml of phenol, which is melted 
in a water bath at 56°C, is added to the stain with a pipette.
2. Decolorizer: It contains 5% aqueous sulfuric acid.
3. Counterstain: It contains methylene blue, 0.3 g and distilled water, 
100 ml. It is prepared by mixing methylene blue with distilled water.





intermittently till carbol fuschin starts steaming. Slide is allowed to 
stain for 7–9 min. More carbol fuschin is added to prevent drying.
•	 The	smear	is	washed	with	distilled	water	and	decolorized	with	5%	
H2SO4 for 1 min.
•	 The	smear	is	then	washed	with	distilled	water,	and	methylene	blue	
is added for 1 min as the counterstain.
•	 Finally,	the	smear	is	washed	with	distilled	water;	water	is	drained	off	
and dried and examined under the microscope using oil immersion 
objective.
The acid-fast oocysts of Cryptosporidium, Isospora, and Cyclospora 
stained red with their typical morphological features. Non-acid fast 
background stains blue with methylene blue.
RESULTS
Various enteric parasites detected in HIV-positive patients and 
HIV-negative individuals are shown in Table 1. For the purpose 
of statistical analysis, the enteric parasites are divided into the 
coccidian group (Cryptosporidium+I. belli) and conventional enteric 
parasites (Entamoeba histolytica, Giardia intestinalis, and Ascaris 
lumbricoides). There is a statistically significant relationship 
between the HIV status and enteric parasites. Enteric parasitic 
infection is more common in HIV-positive individuals (Fisher’s exact 
test, p=0.044, two-sided).
Various enteric parasites detected in HIV-positive patients with/
without diarrhea and in HIV-negative individuals are shown in Table 2. 
Table 1: Enteric parasites detected from HIV-positive patients 
and control group




Cryptosporidium 06 (8) 00
Isospora 01 (1.33) 00
E. histolytica 02 (2.67) 03 (6)
G. intestinalis 03 (4) 02 (4)
A. lumbricoides 01 (1.33) 01 (2)
Total (%) 13 (17.3) 06 (12)
E. histolytica: Entamoeba histolytica, G. intestinalis: Giardia intestinalis, 
A. lumbricoides: Ascaris lumbricoides
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Enteric parasitic infection is more common in HIV-positive patients with 
diarrhea than HIV-positive patient without diarrhea or HIV-negative 
individuals. There is a statistically significant relationship between 
diarrhea and enteric parasites in HIV-infected patients (Fisher’s exact 
test, p=0.021, two-sided).
Details of the HIV-positive patients pertaining to occupation, sexuality, 
marital status, and other risk behaviors are recorded in Table 3. 
Promiscuity appears to be the highest risk factor in HIV-positive group.
Association of intestinal parasitic infection and ART is shown in Table 6. 
It is shown that coccidian parasitic infection is more common in 
patients without ART. However, no statistically significant relationship 
was found between ART status and enteric parasites (Fisher’s exact 
test, p=0.286, two-sided).
DISCUSSION
The present study documents that infection with enteric parasites 
is common in the HIV-positive patients having diarrhea in Kadapa, 
Andhra Pradesh. Of 75 HIV-seropositive cases studied, 18 (24%) cases 
had diarrhea (Table 2). Detection of enteric parasites from HIV-positive 
patients having diarrhea was significantly higher (9/18, 50%) and 
statistically significant (Fisher’s exact test, p=0.021), compared to the 
patients without diarrhea (7.01%) and HIV-negative patients (12%). 
A similar study conducted by Talib and Singh where the isolation 
rate of enteric parasites from HIV-positive patients with diarrhea was 
45.8% (11/24) [1]. Prasad et al. isolated 73% (19/26) of the enteric 
pathogens from the HIV-positive patients with diarrhea [3]. In both 
of these studies, the presence of enteric parasites in HIV-positive 
patients without diarrhea is significantly low, as in our study. Kumar 
et al. isolated 36 enteric pathogens from 100 HIV-positive patients 
having diarrhea (36%), whereas in the same study, isolation rate of 
enteric parasites from HIV-positive patients without diarrhea was 14% 
(7/50) [2]. However, a similar study by Mukhopadhya et al. documented 
that infection with enteric pathogens is common in southern Indian 
HIV-positive patients, regardless of the presence of diarrhea, and the 
overall isolation of enteric pathogens from stool was similar in patients 
with or without diarrhea [4].
Figures from various studies demonstrate striking geographic 
variations in the prevalence of individual pathogens in HIV-infected 
patients. These variations may relate both to the prevalence of 
pathogens within the community and to drugs used prophylactically 
in patients with HIV infections. Isolation rates, in this study (Table 1) 
of Cryptosporidium (8%, reported rates 6–37%), Giardia (4%, reported 
rates 1–11%), and I. belli (1.33%, reported rates 0–3%) from HIV-
positive patients, were within the ranges reported from elsewhere. In 
some recent studies, the isolation rate of I. belli has shown an increasing 
trend - Mukhopadhya et al. (18%) [4], Kumar et al. (13.7%) [2], and 
Prasad et al. (27%) [3], compared with the previous ones - Talib and 
Singh (1.25%) and Ballal et al. (2.86%). The high rate of infection with 
I. belli poses a threat to HIV-positive patients. The actual rate of this 
infection in immuno-compromised individuals and AIDS patients is 
likely to be underestimated due to asymptomatic shedding of oocysts 
and treatment with trimethoprim-sulfamethoxazole for other infections 
in AIDS patients (Pneumocystis carinii pneumonia), which may confer 
some protection against this parasite.
Table 2: Enteric parasites in HIV-positive patients with/without diarrhea and in HIV-negative individuals
Parasite species HIV positive with diarrhea (n=18) HIV positive without diarrhea (n=57) HIV negative individuals (n=50)
Cryptosporidium 06 00 00
Isospora 01 00 00
E. histolytica 01 01 03
G. intestinalis 01 02 02
A. lumbricoides 00 01 01
Total 09 04 06
E. histolytica: Entamoeba histolytica, G. intestinalis: Giardia intestinalis, A. lumbricoides: Ascaris lumbricoides
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Table 6: Association of enteric parasites and ART
Parasites On ART Without ART
Cryptosporidium 02 04
I. belli 00 01
E. histolytica 01 01
G. intestinalis 02 01
A. lumbricoides 01 00
Total 06 08
ART: Antiretroviral therapy, I. belli: Isospora belli, E. histolytica: Entamoeba 
histolytica, G. intestinalis: Giardia intestinalis, A. lumbricoides: Ascaris 
lumbricoides
Age (years) Total number of patients Parasites detected
Male Female Male Female
15–25 19 04 02 01
26–35 16 03 02 03
36–45 11 08 02 02
46–55 08 05 01 00
>55 01 00 00 00
Total 55 20 07 06
04 and females 02
Age (years) Total number of patients Parasites detected
Male Female Male Female
18–30 12 03 02 00
31–40 09 04 01 01
41–50 07 06 00 01
51–60 06 03 01 00
Total 34 16 04 02
Table 4: HIV positive Total 55 males and 20 female  age group of 
15 to 55 selected  in this indiviaual parasites isolated in males 
04 and females 02
Table 5: HIV negative total 34 number of males and 16 females 
in age group of 18 to60,  and individual isolated parasite males 
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The detection rate of Cryptosporidium oocysts from HIV-positive patients 
in our study (8%) is in accordance with the other studies (6–37%). All 
the stool samples positive for Cryptosporidium oocysts were diarrheal. 
Cryptosporidium is also the most prevalent parasite (6/13, 46.1%) in 
our study group of HIV-positive patients. No Cryptosporidium oocysts 
were detected from the HIV-positive patients without diarrhea or 
from HIV-negative individuals. This finding suggests that intestinal 
infestation with Cryptosporidium spp is associated with diarrhea in HIV-
positive patients. A similar study conducted by Mukhopadhya et al. and 
Kumar et al. where the isolation rate of Cryptosporidium oocysts from 
HIV-positive patients without diarrhea was 6% and 8%, respectively. 
However, Talib and Singh also documented that all the Cryptosporidium 
positive stool samples were diarrheal.
In our study group, maximum patients were laborer (41%). Promiscuity 
appeared to be the highest risk factor among the study group. Among 
the 55 male patients, only 6 patients had circumcision while 49 patients 
were uncircumcised. As the socioeconomic status of our study group 
was very poor, so we were unable to get information on the CD4+ count 
of the patients. For four patients, the CD4+ T lymphocyte count done 
elsewhere was recorded and all of them were above 200/µl. Hence, 
the relation between CD4+ count and presence of intestinal parasites 
could not be established. The earlier study showed that intestinal 
opportunistic protozoal infection and diarrhea are more common in 
patients with low CD4+ count [11-13].
Another important finding in our study was that all the microscopy 
positive stool samples for Cryptosporidium oocysts appeared dark 
green to olive green in color and watery to semiformed in consistency. 
The same findings were observed by Nagamani et al. in their study on 
“molecular characterization of Cryptosporidium between 2003 and 
2006” [14]. It was also observed in a few patients that as these samples 
became negative on microscopy, the character of stool changed from 
watery green to formed yellow color [15].
We were unable to identify any mixed enteric infection in our study 
though there are reports about mixed or coinfection in few other 
studies. Shah et al. reported a case of AIDS from Gujarat with coinfection 
with Cryptosporidium, Isospora, and Strongyloides stercoralis [16]. 
Prasad et al. identified two mixed infections, I. belli with S. stercoralis in 
one and the other is Cryptosporidium with E. histolytica [3,17]. Kumar 
et al. reported 3 cases of mixed infection with enteric pathogens in 
HIV-positive patients which includes 2 cases of mixed infection with 
Cryptosporidium and I. belli and one case of Cryptosporidium with 
Ancylostoma duodenale [2,18]. The mixed infections depend on multiple 




to locate/identify a HIV-positive person in a place like Kadapa on 
account	of	confidentiality/lack	of	awareness	among	the	population.
2.	 Having	identified	the	HIV-positive	cases,	a	collection	of	stool	samples	
from the patients also needed counseling and intervention by the 
respective clinicians, especially when patients were not having any 
symptoms.
3.	 Follow-up	of	the	HIV-positive	cases	is	difficult	as	they	lose	contact	
with the clinicians and not traceable after being discharged from the 
hospital.
4.	 As	there	was	difficulty	in	identifying	the	HIV-positive	cases,	having	
located a case we collected stool samples from the patients.
5. Detection of intestinal parasites is 17.3% in HIV-positive patients 
and 12% in HIV-negative individuals.
6. In HIV-positive cases with diarrhea, detection of intestinal parasites is 
50%, whereas in HIV-positive cases without diarrhea, it is only 7.01%.
7. Coccidian parasites Cryptosporidium and Isospora are detected only 
in HIV-positive cases with diarrhea. They are not detected in HIV-
positive cases without diarrhea or HIV-negative individuals.
AUTHOR CONTRIBUTION 






1. Talib SH, Singh J. A study of opportunistic enteric parasites in 80 HIV 
seropositive parients. Indian J Pathol Microbiol 1998;41:31-7.
2. Kumar SS, Ananthan S, Saravanan P. Role of coccidian parasites in 
causation of diarrhoea in HIV infected patients in Chennai. Indian J 
Med Res 2002;116:85-9.
3. Prasad KN, Nag VL, Dhole TN, Ayyagari A. Identification of enteric 
pathogens in HIV-positive patients with diarrhoea in Northern India. 
J Health Popul Nutr 2000;18:23-6.
4. Mukhopadhya A, Ramakrishna BS, Kang G, Anna B. Enteric pathogens 
in southern Indian HIV-infected patients with and without diarrhea. 
Indian J Med Res 1999;109:85-9.
5. Hailemariam G, Kassu A, Abebe G, Abate E, Damte D, Mekonnen E, 
et al. Intestinal parasitic infections in HIV/AIDS and HIV seronegative 
individuals in a teaching hospital, Ethiopia. Jpn J Infect Dis 
2004;57:41-3.
6. Ballal M, Prabhu T, Chandran A, Shivananda PG. Cryptosporidium and 
Isospora belli diarrhoea in immunocompromised hosts. Indian J Cancer 
1999;36:38-42.
7. Kumar SS, Lakshmi P, Ananthan S. Intestinal parasitic infection in HIV 
infected patients in Chennai. Indian J Med Microbiol 2002;20:88-91.
8. Chatterjee KD. Parasitology in Relation to Clinical Medicine. 12th ed. 
New Delhi: Chartterjee Medical Publishers; 1981.
9. Parija SC. Text book of Medical Parasitology. 3rd ed. Chennai: All India 
Publishers & Distributors; 2003.
10. Garcia LS, Bruckner DA, Brewer TC, Shimizu RY. Techniques for 
the recovery and identification of Cryptosporidium oocysts from stool 
specimens. J Clin Microbiol 1983;18:185-90.
11. Hyun G, Lower FC. AIDS and the urologist. Urol Clin North Am 
2003;30:101-9.
12. Muthusamy D, Rao SS, Ramani S, Monica B, Banerjee I, Abraham OC, 
et al. Multilocus genotyping of Cryptosporidium sp. Isolates from 
human immunodeficiency virus-infected individuals in south India. 
J Clin Microbiol 2006;44:632-4.
13. Attili SV, Gulati AK, Singh VP, Varma DV, Rai M, Sundar S, et al. 
Diarrhea, CD4 counts and enteric infections in a hospital - Based 
cohort of HIV-infected patients around Varanasi, India. BMC Infect Dis 
2006;6:39.
14. Nagamani K, Pavuluri PR, Gyaneshwari M, Prasanthi K, Rao MI, 
Saxena NK, et al. Molecular characterisation of Cryptosporidium: An 
emerging parasite. Indian J Med Microbiol 2007;25:133-6.
15. Nagamani K, Rajkumari A, Gyaneshwari. Cryptosporidiosis in a 
tertiary care hospital in Andhra Pradesh. Indian J Med Microbiol 
2001;19:215-6.
16. Shah UV, Purohit BC, Chandralekha D, Mapara MH. Coinfection with 
Cryptosporidium, Isospora and S. stercoralis in a patient with AIDS - A 
case report. Indian J Med Microbiol 2003;21:137-8.
17. Tambekar. Antimicrobial potential treatment in enteric infection. Int J 
Pharm Pharm Sci 2010;2:176-9.
18. Divyashanthi CM. Prevalence and anti-microbial susceptibility pattern 
in admitted patients. Int J Pharm Pharm Sci 2015;7:186-90.
